AHA, Others Challenge FDA Move to Regulate lab-Developed Tests

AHA, others request that the Food and Drug Administration withdraw the proposed draft guidance, Framework for Regulatory Oversight of Laboratory Developed Tests and associated guidance.

Key Resources

Related Resources

Advisory
FDA Rescinds the Laboratory Developed Test Final Regulation
Member
AHA Center for Health Innovation Market Scan
Early Disease Detection: 3 Tech Trends to Watch
Public
Advisory
FDA Issues Final Rule to Regulate Laboratory Developed Tests as Medical Devices
Member
Testimony
AHA Statement on "Evaluating Approaches to Diagnostic Test Regulation and the Impact of FDA’s Proposed Rule."
Letter/Comment
AHA Letter to the FDA on Laboratory Developed Tests (LDTs) Proposed Rule
Case Studies
Lean Six Sigma Reduces Troponin Turnaround Time by 94% for Cardiac Patients in Critical Access Hospital Emergency Department
Public